mortality/aging
• all mice die by 4 months of age
|
neoplasm
• all mice develop tumors at an average age of 3.3 months
• all mice develop gastrointestinal tract tumors and 9% develop non-gastrointestinal tract tumors
|
• all mice develop gastrointestinal tract tumors
• mice exhibit a 30-fold increase in gastrointestinal tumors compared to Mlh1tm1Rak homozygotes
• mice exhibit a 4- to 5-fold increase in stomach and colon tumors, and a 25- to 100-fold increase in duodenum, jejunum, and ileum compared to in homozygous mice
|
• one mouse develops skin carcinoma with lung metastasis
|
• 34% of mice develop microadenomas and 36% adenomas
|
• non-Hodgkin's lymphoma in two mice
|
• mice develop gastrointestinal adenocarcinomas, early invasive carcinomas (in 13% of mice), and carcinomas (in 17% of mice)
|
digestive/alimentary system
• all mice develop gastrointestinal tract tumors
• mice exhibit a 30-fold increase in gastrointestinal tumors compared to Mlh1tm1Rak homozygotes
• mice exhibit a 4- to 5-fold increase in stomach and colon tumors, and a 25- to 100-fold increase in duodenum, jejunum, and ileum compared to in homozygous mice
|
integument
• one mouse develops skin carcinoma with lung metastasis
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
Lynch syndrome | DOID:3883 |
OMIM:PS120435 |
J:53451 |